Hereditary Combined Deficiency of the Vitamin K-Dependent Coagulation Factors

Abstract

Hereditary combined vitamin K-dependent coagulation factor deficiency (VKCFD) is an extremely rare autosomal recessive genetic disorder characterized by deficiencies in vitamin K-dependent coagulation factors and natural anticoagulants. The condition presents with a spectrum of bleeding symptoms ranging from mild to severe, often beginning in the neonatal period. These bleeding episodes can be particularly severe and even life-threatening, occurring spontaneously or during surgery. In addition to bleeding problems, individuals with VKCFD may experience a variety of non-hemostatic problems, including skeletal deformities, cardiovascular abnormalities, and skin conditions.

VKCFD is caused by variants in the genes encoding either γ-glutamyl carboxylase or the vitamin K 2,3-epoxide reductase complex. Both proteins play a critical role in γ-carboxylation, a posttranslational modification that is essential for the proper function of vitamin K-dependent proteins. Timely and accurate diagnosis is essential to differentiate VKCFD from other genetic and acquired disorders, and genetic testing is required to identify the specific variant.

The primary treatment for VKCFD is the administration of vitamin K, with transfusions of fresh frozen plasma often required during surgery or in cases of severe bleeding. In certain situations, alternative therapies such as prothrombin complex concentrates (PCCs) or a combination of recombinant activated factor VII and vitamin K may be considered. With appropriate treatment, individuals with VKCFD generally have a good clinical outcome, and the condition has a limited impact on their quality of life. This article presents a comprehensive review of all 57 VKCFD cases documented in the literature, as well as 4 new, unpublished cases from France.

Keywords

VKCFD - GGCX - VKORC1 - bleeding - vitamin K-dependent coagulation factors

Authors' Contributions

A.R. conducted the literature review, analyzed the data, and drafted the initial version of the article. S.C. performed the genotyping of the four French patients. C.F., C.O., and A.F. are the physicians responsible for managing the four French patients with VKCFD. Y.D. designed the study, supervised the literature review and data analysis, and finalized the manuscript. All authors reviewed and approved the article's content.

Publikationsverlauf

Eingereicht: 17. Januar 2025

Angenommen: 26. März 2025

Artikel online veröffentlicht:
04. Juni 2025

• References

• 1 Oldenburg J, von Brederlow B, Fregin A. et al. Congenital deficiency of vitamin K dependent coagulation factors in two families presents as a genetic defect of the vitamin K-epoxide-reductase-complex. Thromb Haemost 2000; 84 (06) 937-941
• 2 Shearer MJ, Okano T. Key pathways and regulators of vitamin k function and intermediary metabolism. Annu Rev Nutr 2018; 38: 127-151
• 3 Shearer MJ, Fu X, Booth SL. Vitamin K nutrition, metabolism, and requirements: current concepts and future research. Adv Nutr 2012; 3 (02) 182-195
• 4 Schurgers LJ, Teunissen KJF, Hamulyák K, Knapen MHJ, Vik H, Vermeer C. Vitamin K-containing dietary supplements: comparison of synthetic vitamin K1 and natto-derived menaquinone-7. Blood 2007; 109 (08) 3279-3283
• 5 Berkner KL, Runge KW. Vitamin K-dependent protein activation: normal gamma-glutamyl carboxylation and disruption in disease. Int J Mol Sci 2022; 23 (10) 5759
• 6 Oldenburg J, Bevans CG, Müller CR, Watzka M. Vitamin K epoxide reductase complex subunit 1 (VKORC1): the key protein of the vitamin K cycle. Antioxid Redox Signal 2006; 8 (3-4): 347-353
• 7 Chung KS, Bezeaud A, Goldsmith JC, McMillan CW, Ménaché D, Roberts HR. Congenital deficiency of blood clotting factors II, VII, IX, and X. Blood 1979; 53 (04) 776-787
• 8 Card DJ, Gorska R, Harrington DJ. Laboratory assessment of vitamin K status. J Clin Pathol 2020; 73 (02) 70-75
• 9 Napolitano M, Mariani G, Lapecorella M. Hereditary combined deficiency of the vitamin K-dependent clotting factors. Orphanet J Rare Dis 2010; 5 (01) 21
• 10 McMahon MJ, James AH. Combined deficiency of factors II, VII, IX, and X (Borgschulte-Grigsby deficiency) in pregnancy. Obstet Gynecol 2001; 97 (5 Pt 2): 808-809
• 11 Soute BAM, Ulrich MMW, Watson ADJ, Maddison JE, Ebberink RHM, Vermeer C. Congenital deficiency of all vitamin K-dependent blood coagulation factors due to a defective vitamin K-dependent carboxylase in Devon Rex cats. Thromb Haemost 1992; 68 (05) 521-525
• 12 McMillan CW, Roberts HR. Congenital combined deficiency of coagulation factors II, VII, IX and X. Report of a case. N Engl J Med 1966; 274 (23) 1313-1315
• 13 Rost S, Geisen C, Fregin A, Seifried E, Müller CR, Oldenburg J. Founder mutation Arg485Pro led to recurrent compound heterozygous GGCX genotypes in two German patients with VKCFD type 1. Blood Coagul Fibrinolysis 2006; 17 (06) 503-507
• 14 Watzka M, Geisen C, Scheer M. et al. Bleeding and non-bleeding phenotypes in patients with GGCX gene mutations. Thromb Res 2014; 134 (04) 856-865
• 15 Marchetti G, Caruso P, Lunghi B. et al. Vitamin K-induced modification of coagulation phenotype in VKORC1 homozygous deficiency. J Thromb Haemost 2008; 6 (05) 797-803
• 16 Czogalla KJ, Biswas A, Rost S, Watzka M, Oldenburg J. The Arg98Trp mutation in human VKORC1 causing VKCFD2 disrupts a di-arginine-based ER retention motif. Blood 2014; 124 (08) 1354-1362
• 17 Spronk HM, Farah RA, Buchanan GR, Vermeer C, Soute BA. Novel mutation in the gamma-glutamyl carboxylase gene resulting in congenital combined deficiency of all vitamin K-dependent blood coagulation factors. Blood 2000; 96 (10) 3650-3652
• 18 Brenner B, Kuperman AA, Watzka M, Oldenburg J. Vitamin K-dependent coagulation factors deficiency. Semin Thromb Hemost 2009; 35 (04) 439-446
• 19 Tie JK, Carneiro JDA, Jin DY, Martinhago CD, Vermeer C, Stafford DW. Characterization of vitamin K-dependent carboxylase mutations that cause bleeding and nonbleeding disorders. Blood 2016; 127 (15) 1847-1855
• 20 Weston BW, Monahan PE. Familial deficiency of vitamin K-dependent clotting factors. Haemophilia 2008; 14 (06) 1209-1213
• 21 Boneh A, Bar-Ziv J. Hereditary deficiency of vitamin K-dependent coagulation factors with skeletal abnormalities. Am J Med Genet 1996; 65 (03) 241-243
• 22 Cancela ML, Laizé V, Conceição N, Kempf H, Murshed M. Keutel syndrome, a review of 50 years of literature. Front Cell Dev Biol 2021; 9: 642136
• 23 Ghosh S, Oldenburg J, Czogalla-Nitsche KJ. The role of GRP and MGP in the development of non-hemorrhagic VKCFD1 phenotypes. Int J Mol Sci 2022; 23 (02) 798
• 24 Kariminejad A, Bozorgmehr B, Najafi A. et al. Retinitis pigmentosa, cutis laxa, and pseudoxanthoma elasticum-like skin manifestations associated with GGCX mutations. J Invest Dermatol 2014; 134 (09) 2331-2338
• 25 Vanakker OM, Martin L, Gheduzzi D. et al. Pseudoxanthoma elasticum-like phenotype with cutis laxa and multiple coagulation factor deficiency represents a separate genetic entity. J Invest Dermatol 2007; 127 (03) 581-587
• 26 Li Q, Schurgers LJ, Smith ACM, Tsokos M, Uitto J, Cowen EW. Co-existent pseudoxanthoma elasticum and vitamin K-dependent coagulation factor deficiency: compound heterozygosity for mutations in the GGCX gene. Am J Pathol 2009; 174 (02) 534-540
• 27 Pike AC, Brzozowski AM, Roberts SM, Olsen OH, Persson E. Structure of human factor VIIa and its implications for the triggering of blood coagulation. Proc Natl Acad Sci U S A 1999; 96 (16) 8925-8930
• 28 Trossaert M, Chamouard V, Biron-Andreani C. et al. Management of rare inherited bleeding disorders: Proposals of the French Reference Centre on Haemophilia and Rare Coagulation Disorders. Eur J Haematol 2023; 110 (06) 584-601
• 29 Araki S, Shirahata A, Vitamin K. Vitamin K deficiency bleeding in infancy. Nutrients 2020; 12 (03) 780
• 30 Lane PA, Hathaway WE. Vitamin K in infancy. J Pediatr 1985; 106 (03) 351-359
• 31 Ghosh S, Kraus K, Biswas A. et al. GGCX mutations show different responses to vitamin K thereby determining the severity of the hemorrhagic phenotype in VKCFD1 patients. J Thromb Haemost 2021; 19 (06) 1412-1424
• 32 Leissinger CA, Blatt PM, Hoots WK, Ewenstein B. Role of prothrombin complex concentrates in reversing warfarin anticoagulation: a review of the literature. Am J Hematol 2008; 83 (02) 137-143
• 33 Lapecorella M, Napolitano M, Bernardi F. et al. Effective hemostasis during minor surgery in a case of hereditary combined deficiency of vitamin K-dependent clotting factors. Clin Appl Thromb Hemost 2010; 16 (02) 221-223
• 34 Perrone S, Raso S, Napolitano M. Clinical, Laboratory, and molecular characteristics of inherited vitamin K-dependent coagulation factors deficiency. Semin Thromb Hemost 2025; 51 (02) 170-179
• 35 De Vilder EYG, Debacker J, Vanakker OM. GGCX-associated phenotypes: an overview in search of genotype-phenotype correlations. Int J Mol Sci 2017; 18 (02) 240
• 36 Shamseer L, Moher D, Clarke M. et al.; PRISMA-P Group. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ 2015; 350: g7647
• 37 Henrie A, Hemphill SE, Ruiz-Schultz N. et al. ClinVar Miner: Demonstrating utility of a web-based tool for viewing and filtering ClinVar data. Hum Mutat 2018; 39 (08) 1051-1060
• 38 Tullio AN, Accili D, Ferrans VJ. et al. Nonmuscle myosin II-B is required for normal development of the mouse heart. Proc Natl Acad Sci U S A 1997; 94 (23) 12407-12412
• 39 Ma X, Jana SS, Conti MA, Kawamoto S, Claycomb WC, Adelstein RS. Ablation of nonmuscle myosin II-B and II-C reveals a role for nonmuscle myosin II in cardiac myocyte karyokinesis. Mol Biol Cell 2010; 21 (22) 3952-3962